“Can a small, founder-led navigator become the trusted bridge that routes global cancer patients to advanced therapies (CAR-T, gene therapy, trials) in China, India, and other emerging oncology hubs?”
CancerFax was founded in 2019 in India as a cross-border cancer treatment facilitator, initially connecting Indian patients to advanced therapies. It expanded to become a global oncology navigator with particular strength in India-China treatment pathways for CAR-T, gene therapy, and clinical trial access. The company operates as a marketplace/facilitator (not a medical provider), monetizing paid concierge services (case management, visa, interpretation, second opinions) and hospital referrals. It is a small operation (nine full-time staff) owned by Syncare Corporation, and is also the authorized distributor of Aletha Health Inc. physiotherapy products.
CancerFax was founded by Sandeep Kumar Wamne and is founded in 2019, headquartered in Kolkata, India (with offices in Beijing, Hyderabad, Hong Kong, Romania, Cambodia).
Get a read on where your own stack stands against CancerFax and the rest of its category — what they built versus bought, which providers they use, and where the gaps in your own strategy and competitive set actually are.